CIK 0001901440 · Large accelerated filer
UL Solutions Inc.
Sign in to watch- Ticker
- ULS
- Exchange
- NYSE
- Industry
- Services-Testing Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270913800
- Phone
- (847) 272-8800
- Business address
- 333 PFINGSTEN ROAD, NORTHBROOK, IL, 60062
- Former names
- UL Solutions Inc., UL Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,734,738
- in 3 filings, $2.7M under 10b5-1 plans
Net −$2,734,738. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-08 | Shannon James M Director | Grant or award · Deferred Restricted Stock Units | +4 | 2,801 | ||
| 2025-12-08 | PEPPING KAREN K Senior VP & CAO | Grant or award · Restricted Stock Units | +2 | 1,458 | ||
| 2025-12-08 | PEPPING KAREN K Senior VP & CAO | Grant or award · Restricted Stock Units | +2 | 1,302 | ||
| 2025-12-08 | Robinson Ryan D Executive VP & CFO | Grant or award · Restricted Stock Units | +16 | 9,718 | ||
| 2025-12-08 | Robinson Ryan D Executive VP & CFO | Grant or award · Restricted Stock Units | +15 | 9,267 | ||
| 2025-12-08 | SUSMAN SALLY Director | Grant or award · Deferred Restricted Stock Units | +8 | 4,954 | ||
| 2025-12-08 | SUSMAN SALLY Director | Grant or award · Deferred Restricted Stock Units | +4 | 2,801 | ||
| 2025-12-08 | GOTTSCHALK MARLA C Director | Grant or award · Deferred Restricted Stock Units | +8 | 4,954 | ||
| 2025-12-08 | GOTTSCHALK MARLA C Director | Grant or award · Deferred Restricted Stock Units | +4 | 2,801 | ||
| 2025-12-08 | THAMAN MICHAEL H Director | Grant or award · Restricted Stock Units | +4 | 2,801 | ||
| 2025-12-08 | DOLLIVE JAMES P Director | Grant or award · Restricted Stock Units | +4 | 2,801 | ||
| 2025-12-08 | KENNEDY KEVIN Director | Grant or award · Deferred Restricted Stock Units | +8 | 4,954 | ||
| 2025-12-08 | KENNEDY KEVIN Director | Grant or award · Deferred Restricted Stock Units | +4 | 2,801 | ||
| 2025-12-05 | ULSE Inc. 10% owner | Conversion | +12,500,000 | 12,500,000 | ||
| 2025-12-05 | ULSE Inc. 10% owner | Sale | −12,500,000 | $78.00 | $975.0M | 0 |
| 2025-12-05 | ULSE Inc. 10% owner | Conversion · Class B Common Stock | −12,500,000 | 125,630,000 | ||
| 2025-10-03 | Shannon James M Director | Grant or award · Deferred Stock Units | +203 | 1,443 | ||
| 2025-09-08 | Genovesi John A See Remarks | Purchase | +37 | $63.59 | $2K | 31,050 |
| 2025-09-08 | D'Angelo Scott EVP, CLO & Corporate Secy | Grant or award · Restricted Stock Units | +17 | 8,595 | ||
| 2025-09-08 | D'Angelo Scott EVP, CLO & Corporate Secy | Grant or award · Restricted Stock Units | +7 | 3,581 |
Page 19 of 24 · 474 trades